Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD
Authors:
- Fernando De BenedettoFBFernando De Benedetto
- Antonio AcetoAAAntonio Aceto
- Beatrice DraganiBDBeatrice Dragani
- Antonella SpaconeASAntonella Spacone
- Stefano FormisanoSFStefano Formisano
- Riccardo PelaRPRiccardo Pela
- Claudio F. DonnerCDClaudio F. Donner
- Claudio M. SanguinettiCSClaudio M. Sanguinetti
- 1 February 2005
- journal article
- clinical trial
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 18 (1) , 41-47
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effects of Inhaled Corticosteroids with Different Lung Deposition on Exhaled Hydrogen Peroxide in Stable COPD PatientsRespiration, 2003
- Hydrogen Peroxide–Scavenging Properties of Normal Human Airway SecretionsAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Exhaled Nitric Oxide and Hydrogen Peroxide in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic reviewEuropean Respiratory Journal, 2000
- OXIDATIVE STRESS AND PULMONARY INFLAMMATION: PHARMACOLOGICAL INTERVENTION WITH ANTIOXIDANTSPharmacological Research, 1999
- Oxidants and Antioxidants as Therapeutic Targets in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Oxidative Stress in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Increased Exhalation of Hydrogen Peroxide in Patients With Stable and Unstable Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Antioxidants in Human Health and DiseaseAnnual Review of Nutrition, 1996
- Lung Protection by a Thiol-Containing Antioxidant: N-AcetylcysteineRespiration, 1986